← Open Payments lookup

KATELEEN PENDERGRASS: Open Payments

NPI 1184214124 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,208 in 109 payments from 17 companies in 2025. Trend: 2023 $1,189 · 2024 $2,140 · 2025 $2,208

Food & beverage: $2,208
CompanyPaymentsAmount
ABBVIE INC.30$574
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$330
Takeda Pharmaceuticals U.S.A., Inc.14$277
Madrigal Pharmaceuticals10$251
Janssen Biotech, Inc.9$142
Aimmune Therapeutics, Inc.5$119
Gilead Sciences, Inc.4$108
Phathom Pharmaceuticals, Inc.5$83
PFIZER INC.4$78
QOL Medical, LLC2$59

Products named: XIFAXAN, ENTYVIO, REZDIFFRA, CREON, RINVOQ, LINZESS, TREMFYA, ZENPEP.

Industry payments across GA — which companies pay providers there.